Checkpoint Inhibitors Spur Changes in Trial Design [News in Depth]

Adaptive studies, novel endpoints, new preclinical models address research challenges.

from Cancer via ola Kala on Inoreader http://ift.tt/2xvlTMA
via IFTTT